L - R: Dr Satyaprakash Pandey, Senior Scientist, TIGS, Dr Gayatri R Iyer, Scientist, TIGS, Dr Saroj Kumar Sabath, Associate Vice President - Regulatory, Max Healthcare, Dr Rakesh Mishra, Director, TIGS, Dr Sandeep Budhiraja, Group Medical Director, Max Healthcare, Dr Nitin Dayal, Associate Director & Chief - Haemato Pathology and Immuno Haematology, Max Healthcare, Dr Manish Malik, Director, Paediatrics - NICU, Dr Vinitaa Jha, Director - Research and Academics, Max Healthcare, Jatin Sharma, Senior Executive - Legal, Max Healthcare, Dr Poorvee Mathur, General Manager - Grants, Partnerships, and New Initiatives, Max Healthcare. Credits: Express Healthcare
New Collaboration to Drive Innovation in Clinical Genetics Max Healthcare, one of India’s leading private healthcare providers, has entered into a strategic partnership with the Tata Institute for Genetics and Society (TIGS), a premier genomics research institute. The two organisations signed a Memorandum of Understanding (MoU) to establish a collaborative platform for research, training, and knowledge exchange in genetics and healthcare. The partnership aims to integrate genomic insights into clinical practice to enhance patient outcomes and advance medical science in India.
Focus on Translational Genomics and Personalised Care As reported by Express Healthcare, the MoU, signed at a formal ceremony attended by representatives from both institutions, outlines a shared vision to apply genomic research to real-world healthcare challenges. The collaboration will centre on joint research in rare genetic diseases, neonatal care, and the development of personalised medicine based on genetic profiling. By combining TIGS’s expertise in genomics with Max Healthcare’s clinical knowledge and patient data, the partnership seeks to transform research findings into actionable clinical applications.
Building Capacity Through Knowledge Exchange To foster scientific exchange, the partnership will organise conferences, workshops, and specialised training programmes. These initiatives will encourage collaboration between scientists, clinicians, and researchers from both organisations. Max Healthcare will provide its extensive clinical expertise and patient data, while TIGS will contribute its advanced genomics research capabilities. Together, they aim to bridge the gap between laboratory discoveries and patient care.
Leaders Emphasise the Promise of Genomic Integration Commenting on the collaboration, Dr. Sandeep Budhiraja, Group Medical Director at Max Healthcare, stated, “This partnership with the Tata Institute for Genetics and Society is a significant step forward in our commitment to bringing the latest advancements in medical sciences to our patients. By integrating genomics into our clinical practice, we can move towards a future of more personalised and effective healthcare. This collaboration will undoubtedly enhance our capabilities in clinical research and innovation, ultimately benefiting our patients and the broader healthcare landscape in India.”
Echoing this sentiment, Dr. Rakesh Mishra, Director of TIGS, said, “At TIGS, our mission is to use cutting-edge science to solve societal problems. This collaboration with Max Healthcare provides a unique opportunity to apply our expertise in genomics to real-world clinical challenges. By working closely with clinicians and patients at Max Healthcare, we can ensure that our research is relevant, impactful, and translates into tangible benefits for society.”
Expanding Research in Haematology and Neonatal Genetics As part of the collaboration, the two institutions will focus on genetics related to haematology and neonatal care. Their joint research will explore the genetic basis of blood disorders, cancers, and neonatal conditions. Furthermore, the initiative will support early diagnosis, personalised treatment planning, and identification of genetic risk factors in newborns—paving the way for improved patient outcomes and precision medicine in India.
